| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2200635 | 重组乙型肝炎疫苗（汉逊酵母，CpG和铝佐剂） | Recombinant Hepatitis B Vaccine(Hansenula Polymorpha) | Injection | Biological Products(1.3) | New Drug Application | 2022-12-31 | Yuanda Weixin Life Science (Nanjing) Co Ltd | view |